Mohammad Mehraban, PhD, MS

Title(s)Postdoctoral Scholar, Pathology
SchoolSchool of Medicine
Address513 Parnassus Avenue, HSW, #501
San Francisco CA 94143
Phone--
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Clinical and experimental bacteriophage studies: Recommendations for possible approaches for standing against SARS-CoV-2. Microb Pathog. 2022 Mar; 164:105442. Shahin K, Zhang L, Mehraban MH, Collard JM, Hedayatkhah A, Mansoorianfar M, Soleimani-Delfan A, Wang R. PMID: 35151823; PMCID: PMC8830156.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    2. MiR-26a and miR-26b downregulate the expression of sucrase-isomaltase enzyme: A new chapter in diabetes treatment. Biochem Biophys Res Commun. 2019 10 29; 519(1):192-197. Mehraban MH, Motovali-Bashi M, Ghasemi Y. PMID: 31493868.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Maltase-glucoamylase inhibition potency and cytotoxicity of pyrimidine-fused compounds: An in silico and in vitro approach. Comput Biol Chem. 2019 Oct; 82:25-36. Mehraban MH, Mansourian M, Ahrari S, HajiEbrahimi A, Odooli S, Motovali-Bashi M, Yousefi R, Ghasemi Y. PMID: 31255972.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    4. The interaction of beta-lactoglobulin with ciprofloxacin and kanamycin; a spectroscopic and molecular modeling approach. J Biomol Struct Dyn. 2017 Jul; 35(9):1968-1978. Mehraban MH, Odooli S, Yousefi R, Roghanian R, Motovali-Bashi M, Moosavi-Movahedi AA, Ghasemi Y. PMID: 27562530.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    5. Binding study of novel anti-diabetic pyrimidine fused heterocycles to β-lactoglobulin as a carrier protein. Colloids Surf B Biointerfaces. 2013 Dec 01; 112:374-9. Mehraban MH, Yousefi R, Taheri-Kafrani A, Panahi F, Khalafi-Nezhad A. PMID: 24028850.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    6. Synthesis of new pyrimidine-fused derivatives as potent and selective antidiabetic α-glucosidase inhibitors. Carbohydr Res. 2013 Oct 18; 380:81-91. Panahi F, Yousefi R, Mehraban MH, Khalafi-Nezhad A. PMID: 23978663.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    7. Pyrimidine-fused heterocycle derivatives as a novel class of inhibitors for α-glucosidase. J Enzyme Inhib Med Chem. 2013 Dec; 28(6):1228-35. Yousefi R, Alavian-Mehr MM, Mokhtari F, Panahi F, Mehraban MH, Khalafi-Nezhad A. PMID: 23043430.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells